Interestingly, RGS1 was positively correlated with the abundance of neutrophils, myeloid DCs, and CD8+ T cells in tumors, and RGS1 expression was markedly down-regulated in patients with high tumor immune infiltration. This evidence concerns the gene RGS1 and neoplasm.